Paragon Capital Management (Utah)’s Maravai LifeSciences MRVI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,587	Closed	-$178K	–	74
2024 Q1	$178K	Sell	20,587 -237,640	-92%	-$2.06M	0.13%	64
2023 Q4	$1.69M	Buy	258,227 +139,074	+117%	+$911K	1.35%	19
2023 Q3	$1.19M	Buy	119,153 +26,612	+29%	+$266K	1.02%	41
2023 Q2	$1.15M	Buy	+92,541	New	+$1.15M	0.97%	43